John H. Tucker

John H. Tucker (chief executive) discloses dealings in 2 companies, chiefly scPharmaceuticals Inc. and Indevus Pharmaceuticals Inc. Between 7 March 2006 and 7 October 2025, the trades on record add up to 14 filings.

No open-market sale appears; the market trades are 2 purchases worth €58k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 8 share grants and 2 option exercises.

On 7 October 2025 came the latest disclosure, a transaction in scPharmaceuticals Inc. The clock since the last published purchase (6 December 2021) now reads 1,783 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.